HOUSTON, Dec. 19, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the 31 st Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2013, in San Francisco.
Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 10:00 AM Pacific Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at http://www.cyberonics.com on January 9, 2013.
About Cyberonics, Inc. and the VNS Therapy ® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.Additional information on Cyberonics and the VNS Therapy System is available at www.cyberonics.com . Contact Information Greg Browne, CFOCyberonics, Inc.100 Cyberonics Blvd. Houston, TX 77058Main: (281) 228-7262 Fax: (281) 218-9332 firstname.lastname@example.org SOURCE Cyberonics, Inc.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts